Header Logo

David Gurka

Concepts (102)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intensive Care Units
5
2021
234
1.040
Why?
Positive-Pressure Respiration
1
2021
7
0.720
Why?
Patient Discharge
3
2016
147
0.480
Why?
Physician-Nurse Relations
1
2015
3
0.480
Why?
Acute Lung Injury
4
2016
18
0.470
Why?
Electronic Health Records
1
2015
64
0.450
Why?
Communication
1
2015
96
0.440
Why?
Enteral Nutrition
4
2014
59
0.360
Why?
C-Reactive Protein
3
2016
92
0.330
Why?
Insufflation
1
2007
1
0.280
Why?
Calorimetry
1
2007
4
0.280
Why?
Intubation, Gastrointestinal
1
2007
11
0.270
Why?
Capnography
1
2007
8
0.270
Why?
Carbon Dioxide
1
2007
17
0.270
Why?
Energy Intake
3
2016
77
0.240
Why?
Hospital Mortality
4
2021
129
0.230
Why?
Shock, Septic
3
2012
25
0.210
Why?
Intubation, Intratracheal
2
2017
82
0.190
Why?
Intermittent Positive-Pressure Ventilation
1
2021
4
0.180
Why?
Respiration, Artificial
3
2017
84
0.180
Why?
Humans
15
2021
22823
0.170
Why?
Reproducibility of Results
1
2021
591
0.160
Why?
Anti-Infective Agents
2
2012
27
0.160
Why?
Dietary Proteins
3
2016
26
0.150
Why?
Airway Resistance
1
2017
4
0.140
Why?
Decontamination
1
2017
9
0.130
Why?
Ventilator Weaning
1
2017
20
0.130
Why?
Nutritional Support
1
2016
23
0.130
Why?
United States
4
2015
1762
0.120
Why?
Patient Transfer
1
2015
24
0.110
Why?
Protein C
2
2012
6
0.110
Why?
Leukoencephalitis, Acute Hemorrhagic
1
2013
2
0.100
Why?
Brain Edema
1
2013
16
0.100
Why?
Encephalocele
1
2013
17
0.100
Why?
Influenza A Virus, H1N1 Subtype
1
2013
17
0.100
Why?
Influenza, Human
1
2013
40
0.100
Why?
Critical Care
2
2012
97
0.100
Why?
Nutrition Therapy
1
2012
6
0.090
Why?
Critical Illness
1
2012
97
0.090
Why?
Prospective Studies
3
2014
1487
0.080
Why?
Proportional Hazards Models
3
2016
270
0.080
Why?
Male
9
2016
12400
0.080
Why?
Nursing Audit
1
2007
1
0.070
Why?
Medical Errors
1
2007
25
0.070
Why?
Female
8
2016
12904
0.070
Why?
Point-of-Care Systems
1
2007
58
0.060
Why?
Adult
6
2016
6896
0.060
Why?
Hypotension
1
2006
20
0.060
Why?
Radiography
1
2007
523
0.060
Why?
Middle Aged
6
2016
7873
0.060
Why?
Nutritional Status
2
2016
51
0.050
Why?
APACHE
2
2014
22
0.050
Why?
Sepsis
1
2003
75
0.050
Why?
Aged
4
2016
7412
0.040
Why?
Recombinant Proteins
2
2012
162
0.040
Why?
Cohort Studies
2
2012
1412
0.040
Why?
Work of Breathing
1
2017
5
0.030
Why?
Mucus
1
2017
6
0.030
Why?
Biofilms
1
2017
13
0.030
Why?
Cross-Over Studies
1
2016
64
0.030
Why?
Treatment Outcome
2
2014
2934
0.030
Why?
Hospital Bed Capacity
1
2015
4
0.030
Why?
Blood Cell Count
1
2014
12
0.030
Why?
Parenteral Nutrition
1
2014
19
0.030
Why?
Survival Rate
2
2006
312
0.030
Why?
Autoimmunity
1
2013
11
0.030
Why?
Body Weight
1
2014
129
0.030
Why?
Fatal Outcome
1
2013
50
0.030
Why?
Pilot Projects
1
2015
370
0.030
Why?
Blood Glucose
1
2014
99
0.030
Why?
Saudi Arabia
1
2012
2
0.020
Why?
Canada
1
2012
42
0.020
Why?
Propensity Score
1
2012
33
0.020
Why?
Body Mass Index
1
2014
377
0.020
Why?
Length of Stay
1
2012
298
0.020
Why?
Manitoba
1
2006
1
0.020
Why?
Odds Ratio
1
2006
217
0.010
Why?
Prevalence
1
2006
375
0.010
Why?
Gastrointestinal Contents
1
2004
2
0.010
Why?
Sampling Studies
1
2004
23
0.010
Why?
Gastric Emptying
1
2004
12
0.010
Why?
Nutritional Requirements
1
2004
15
0.010
Why?
Nausea
1
2004
24
0.010
Why?
Vomiting
1
2004
18
0.010
Why?
Nutrition Assessment
1
2004
39
0.010
Why?
Diarrhea
1
2004
31
0.010
Why?
Norepinephrine
1
2003
28
0.010
Why?
Ventilators, Mechanical
1
2003
19
0.010
Why?
Vasoconstrictor Agents
1
2003
19
0.010
Why?
Hyperglycemia
1
2003
27
0.010
Why?
Insulin
1
2003
77
0.010
Why?
Acute Disease
1
2003
162
0.010
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2003
86
0.010
Why?
Time Factors
1
2006
1258
0.010
Why?
Adrenal Cortex Hormones
1
2003
95
0.010
Why?
Clinical Trials as Topic
1
2003
190
0.010
Why?
Follow-Up Studies
1
2006
1412
0.010
Why?
Chicago
1
2004
811
0.010
Why?
Prognosis
1
2003
714
0.010
Why?
Anti-Bacterial Agents
1
2003
362
0.010
Why?
Retrospective Studies
1
2006
2976
0.010
Why?
Aged, 80 and over
1
2004
3717
0.010
Why?
Gurka's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (102)
Explore
_
Co-Authors (7)
Explore
_
Same Department Expand Description
Explore
_